Deutsche Bank’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $439K | Buy |
16,247
+1,592
| +11% | +$53.5K | ﹤0.01% | 2639 |
|
|
2025
Q4 | $628K | Buy |
14,655
+570
| +4% | +$21.5K | ﹤0.01% | 2454 |
|
|
2025
Q3 | $399K | Buy |
14,085
+23
| +0.2% | +$688 | ﹤0.01% | 2671 |
|
|
2025
Q2 | $263K | Buy |
14,062
+2,026
| +17% | +$38.4K | ﹤0.01% | 2812 |
|
|
2025
Q1 | $217K | Sell |
12,036
-1,708
| -12% | -$34.7K | ﹤0.01% | 2911 |
|
|
2024
Q4 | $231K | Buy |
13,744
+6,890
| +101% | +$132K | ﹤0.01% | 3034 |
|
|
2024
Q3 | $111K | Buy |
6,854
+93
| +1% | +$1.09K | ﹤0.01% | 3186 |
|
|
2024
Q2 | $55.6K | Sell |
6,761
-1,694
| -20% | -$17.7K | ﹤0.01% | 3303 |
|
|
2024
Q1 | $125K | Buy |
8,455
+302
| +4% | +$4.07K | ﹤0.01% | 3062 |
|
|
2023
Q4 | $118K | Buy |
8,153
+261
| +3% | +$2.67K | ﹤0.01% | 3144 |
|
|
2023
Q3 | $85.2K | Buy |
7,892
+1,510
| +24% | +$18.2K | ﹤0.01% | 3231 |
|
|
2023
Q2 | $82.3K | Sell |
6,382
-4,950
| -44% | -$66.9K | ﹤0.01% | 3351 |
|
|
2023
Q1 | $150K | Buy |
11,332
+3,707
| +49% | +$58.9K | ﹤0.01% | 3144 |
|
|
2022
Q4 | $114K | Buy |
7,625
+116
| +2% | +$1.06K | ﹤0.01% | 3267 |
|
|
2022
Q3 | $89K | Sell |
7,509
-1,153
| -13% | -$15.6K | ﹤0.01% | 3380 |
|
|
2022
Q2 | $98K | Sell |
8,662
-1,171
| -12% | -$23.5K | ﹤0.01% | 3537 |
|
|
2022
Q1 | $294K | Sell |
9,833
-1,362
| -12% | -$36.9K | ﹤0.01% | 3049 |
|
|
2021
Q4 | $297K | Buy |
11,195
+549
| +5% | +$16.6K | ﹤0.01% | 3158 |
|
|
2021
Q3 | $387K | Sell |
10,646
-317
| -3% | -$12.5K | ﹤0.01% | 3197 |
|
|
2021
Q2 | $476K | Sell |
10,963
-743
| -6% | -$28.1K | ﹤0.01% | 3258 |
|
|
2021
Q1 | $400K | Sell |
11,706
-1,035
| -8% | -$41K | ﹤0.01% | 3241 |
|
|
2020
Q4 | $446K | Buy |
12,741
+289
| +2% | +$8.37K | ﹤0.01% | 2985 |
|
|
2020
Q3 | $299K | Buy |
12,452
+3,811
| +44% | +$93.6K | ﹤0.01% | 2969 |
|
|
2020
Q2 | $158K | Buy |
8,641
+2,921
| +51% | +$52.5K | ﹤0.01% | 3241 |
|
|
2020
Q1 | $90K | Sell |
5,720
-51,737
| -90% | -$1.1M | ﹤0.01% | 3298 |
|
|
2019
Q4 | $1.23M | Buy |
57,457
+5,849
| +11% | +$120K | ﹤0.01% | 2254 |
|
|
2019
Q3 | $963K | Sell |
51,608
-64,377
| -56% | -$1.33M | ﹤0.01% | 2326 |
|
|
2019
Q2 | $3.03M | Sell |
115,985
-79,932
| -41% | -$1.8M | ﹤0.01% | 2117 |
|
|
2019
Q1 | $5.03M | Buy |
195,917
+39,801
| +25% | +$910K | ﹤0.01% | 1871 |
|
|
2018
Q4 | $3.59M | Sell |
156,116
-6,921
| -4% | -$195K | ﹤0.01% | 2009 |
|
|
2018
Q3 | $5.23M | Sell |
163,037
-35
| -0% | -$1.05K | ﹤0.01% | 2162 |
|
|
2018
Q2 | $4.61M | Buy |
163,072
+32,433
| +25% | +$1.15M | ﹤0.01% | 2356 |
|
|
2018
Q1 | $4.62M | Buy |
130,639
+22,873
| +21% | +$916K | ﹤0.01% | 2283 |
|
|
2017
Q4 | $4.18M | Buy |
107,766
+78,484
| +268% | +$2.99M | ﹤0.01% | 2160 |
|
|
2017
Q3 | $742K | Sell |
29,282
-17,289
| -37% | -$420K | ﹤0.01% | 3197 |
|
|
2017
Q2 | $1.27M | Sell |
46,571
-854
| -2% | -$23.4K | ﹤0.01% | 2858 |
|
|
2017
Q1 | $1.57M | Sell |
47,425
-12,233
| -21% | -$312K | ﹤0.01% | 2394 |
|
|
2016
Q4 | $1.42M | Buy |
59,658
+33,652
| +129% | +$964K | ﹤0.01% | 2470 |
|
|
2016
Q3 | $953K | Buy |
26,006
+19,546
| +303% | +$560K | ﹤0.01% | 2851 |
|
|
2016
Q2 | $143K | Buy |
6,460
+1,164
| +22% | +$28.9K | ﹤0.01% | 3924 |
|
|
2016
Q1 | $109K | Sell |
5,296
-953
| -15% | -$23.5K | ﹤0.01% | 3966 |
|
|
2015
Q4 | $188K | Sell |
6,249
-375
| -6% | -$11.4K | ﹤0.01% | 3756 |
|
|
2015
Q3 | $162K | Buy |
6,624
+283
| +4% | +$8.45K | ﹤0.01% | 3890 |
|
|
2015
Q2 | $201K | Sell |
6,341
-13,506
| -68% | -$516K | ﹤0.01% | 3887 |
|
|
2015
Q1 | $708K | Sell |
19,847
-937
| -5% | -$25.7K | ﹤0.01% | 3110 |
|
|
2014
Q4 | $470K | Sell |
20,784
-7,465
| -26% | -$151K | ﹤0.01% | 3716 |
|
|
2014
Q3 | $546K | Sell |
28,249
-12,962
| -31% | -$366K | ﹤0.01% | 3432 |
|
|
2014
Q2 | $1.49M | Buy |
41,211
+671
| +2% | +$22.8K | ﹤0.01% | 2649 |
|
|
2014
Q1 | $1.57M | Sell |
40,540
-10,225
| -20% | -$365K | ﹤0.01% | 2554 |
|
|
2013
Q4 | $1.44M | Sell |
50,765
-13,678
| -21% | -$401K | ﹤0.01% | 2451 |
|
|
2013
Q3 | $2.31M | Sell |
64,443
-796
| -1% | -$29.1K | ﹤0.01% | 2380 |
|
|
2013
Q2 | $2.18M | Buy |
+65,239
| New | +$2.96M | ﹤0.01% | 2167 |
|
Other funds holding RIGL
AC
VCM
Deutsche Bank's RIGL Position: Q1 2026 in Review
Deutsche Bank increased its Rigel Pharmaceuticals (RIGL) stake by 11% in Q1 2026, buying an estimated $53.5K and bringing the position to 16,247 shares worth $439K. The position accounts for ﹤0.01% of the portfolio, ranked #2639.
Deutsche Bank first reported a position in RIGL in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.23M in Q3 2018. 159 funds tracked by Wall St. Rank hold RIGL as of Q1 2026.
- Deutsche Bank held 16,247 shares of Rigel Pharmaceuticals worth $439K as of Q1 2026.
- Deutsche Bank bought 1,592 Rigel Pharmaceuticals shares in Q1 2026, an estimated $53.5K.
- Rigel Pharmaceuticals made up ﹤0.01% of Deutsche Bank's portfolio in Q1 2026, its #2639 holding.
- Deutsche Bank first reported a position in Rigel Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Deutsche Bank's Rigel Pharmaceuticals position peaked at $5.23M in Q3 2018.
- 159 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q1 2026.
Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.